The IB contains both clinical and non-clinical data pertaining to an investigational product (IP) and a complete dossier is provided to the principal investigator prior to the start of a clinical trial.
The IB contains both clinical and non-clinical data pertaining to the new drug. The pharmaceutical company sponsoring the study provides a copy to each principal investigator (local researcher) prior to the start of a clinical trial.